Cargando…

Predictive Value of Pro-BNP for Heart Failure Readmission after an Acute Coronary Syndrome

Background: N-terminal pro-brain natural peptide (NT-pro-BNP) is a well-established biomarker of tissue congestion and has prognostic value in patients with heart failure (HF). Nonetheless, there is scarce evidence on its predictive capacity for HF re-admission after an acute coronary syndrome (ACS)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cordero, Alberto, Martínez Rey-Rañal, Elías, Moreno, María J., Escribano, David, Moreno-Arribas, José, Quintanilla, Maria A., Zuazola, Pilar, Núñez, Julio, Bertomeu-González, Vicente
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069470/ https://www.ncbi.nlm.nih.gov/pubmed/33924437 http://dx.doi.org/10.3390/jcm10081653

Ejemplares similares

Increased Risk of Heart Failure in Elderly Patients Treated with Beta-Blockers After AV Node Ablation
por: Bertomeu-Gonzalez, Vicente, et al.
Publicado: (2023)

Understanding Erectile Dysfunction in Hypertensive Patients: The Need for Good Patient Management
por: Hernández-Cerda, Jorge, et al.
Publicado: (2020)

Effect of insulin on readmission for heart failure following a hospitalization for acute heart failure
por: Bertomeu‐Gonzalez, Vicente, et al.
Publicado: (2020)

HDL Function and Size in Patients with On-Target LDL Plasma Levels and a First-Onset ACS
por: Cordero, Alberto, et al.
Publicado: (2023)

Most Recent Trials and Advances in Hypertension
por: Rey-Rañal, Elías Martínez, et al.
Publicado: (2022)

Direct Immunochemiluminescent Assay for proBNP and Total BNP in Human Plasma proBNP and Total BNP Levels in Normal and Heart Failure
por: Nishikimi, Toshio, et al.
Publicado: (2013)

Mortality associated with cardiovascular disease in patients with COVID-19()
por: Cordero, Alberto, et al.
Publicado: (2021)

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)

Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
por: Alawieh, Hussein, et al.
Publicado: (2019)

Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023)

A comparison of the prognostic value of BNP versus NT-proBNP after hospitalisation for heart failure
por: Linssen, G. C. M., et al.
Publicado: (2018)

Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients
por: Cabré, Anna, et al.
Publicado: (2013)

The Potential Role of Salivary NT-proBNP in Heart Failure
por: Rammos, Aidonis, et al.
Publicado: (2023)

Complicaciones cardiovasculares y pronóstico en pacientes con COVID-19
por: Cordero, Alberto, et al.
Publicado: (2020)

One-year outcomes in patients with COVID-19 and clinical heart failure or elevated NT-proBNP
por: Caro-Codón, Juan, et al.
Publicado: (2023)

Using NT-proBNP as a criterion for heart failure hospitalization
por: Tamizifar, Babak, et al.
Publicado: (2012)

The relationship between NT-proBNP and Depression in Patients with Heart Failure
por: Gao, Ying–Hui, et al.
Publicado: (2017)

NT-proBNP and postoperative heart failure in surgery for aortic stenosis
por: Jiang, Huiqi, et al.
Publicado: (2019)

NT‐proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme
por: Sweeney, Claire, et al.
Publicado: (2021)

The Ability of Heart Failure Specialists to Accurately Predict NT-proBNP Levels Based on Clinical Assessment and a Previous NT-proBNP Measurement
por: Sedlak, Tara L, et al.
Publicado: (2008)

Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013)

Impact of high intensity interval and moderate continuous training on plasma ratios of ProBNP(1-108)/BNP(1-32) and NT-pro-BNP(1-76)/BNP(1-32) after coronary artery bypass grafting surgery
por: Zare Karizak, Sara, et al.
Publicado: (2023)

ASA Status, NPPA/NPPB Haplotype and Coronary Artery Disease Have an Impact on BNP/NT-proBNP Plasma Levels
por: Hahn, Markus, et al.
Publicado: (2022)

NT-ProBNP Levels in Saliva and Its Clinical Relevance to Heart Failure
por: Foo, Jared Yong Yang, et al.
Publicado: (2012)

NT-proBNP: A Guide to Improve the Management of Patients with Heart Failure
por: Latini, Roberto, et al.
Publicado: (2014)

Chronic heart failure treatment benefits from pro-BNP-directed therapy
por: J, Aalbers
Publicado: (2011)

NT-proBNP test with improved accuracy for the diagnosis of chronic heart failure
por: Pan, Yesheng, et al.
Publicado: (2017)

NT-proBNP as a neuroendocrine tumor biomarker: beyond heart failure
por: Komarnicki, Paweł, et al.
Publicado: (2023)

Risk factors for pre‐heart failure or symptomatic heart failure based on NT‐proBNP
por: Aoki, Shoko, et al.
Publicado: (2022)

Myocarditis after RNA-based vaccines for coronavirus.
por: Cordero, Alberto, et al.
Publicado: (2022)

Higher BNP/NT‐pro BNP levels stratify prognosis equally well in patients with and without heart failure: a meta‐analysis
por: Hendricks, Stefanie, et al.
Publicado: (2022)

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
por: Lewis, Robert A., et al.
Publicado: (2020)

Sex differences in uric acid and NT-pro BNP assessments during coronary severity
por: Guo, Guofeng, et al.
Publicado: (2020)

Comparative accuracy of NT‐proBNP and MR‐proANP for the diagnosis of acute heart failure in dyspnoeic patients
por: Darche, Fabrice F., et al.
Publicado: (2017)

Sensitivity and specificity of NT-proBNP to detect heart failure at post mortem examination
por: Sabatasso, Sara, et al.
Publicado: (2011)

Inflammatory markers and incident heart failure in older men: the role of NT-proBNP
por: McKechnie, Douglas GJ, et al.
Publicado: (2021)

NT‐proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure
por: Schmitt, Walter, et al.
Publicado: (2021)

Cardiovascular medication in patients with raised NT-proBNP, but no heart failure in the SHEAF registry
por: Wolodimeroff, Elena, et al.
Publicado: (2022)

Prognostic value of RDW alone and in combination with NT‐proBNP in patients with heart failure
por: Liang, Lin, et al.
Publicado: (2022)

Variability of NT-proBNP and Its Relationship with Inflammatory Status in Patients with Stable Essential Hypertension: A 2-Year Follow-Up Study
por: Roselló-Lletí, Esther, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_td5o61ou086tmj6nhv3e0fjghj